Jazz Pharmaceuticals Receives FDA Approval for Two Advanced Gastric Cancer Regimens
Observed price moves
- JAZZ-0.32%15 min after this headline
- ONC-0.08%15 min after this headline
- ZYME+0.11%15 min after this headline
MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next. We pay about $120,000 a month for the newswires behind this feed.